InMed Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. InMed Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11% to $4,597,730. The net income raised on -$7,675,550 and profit margin reached -167%. Total operating expenses were $9,015,743,000.
Profit Margin
| 2015 | 0 | -3.45M | |
|---|---|---|---|
| 2016 | 0 | -1.83M | |
| 2017 | 0 | -3.43M | |
| 2018 | 0 | -6.70M | |
| 2019 | 0 | -9.83M | |
| 2020 | 0 | -8.94M | |
| 2021 | 0 | -10.56M | |
| 2022 | 1.08M | -23.40M | -2148.68% |
| 2023 | 4.13M | -7.94M | -192.18% |
| 2024 | 4.59M | -7.67M | -166.94% |
INM Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 4.59M | 4.13M | 1.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 3.49M | 2.73M | 545.88K | 197.03K | 183.09K | 93.94K | 92.77K | 0 | 0 | 0 |
Gross profit | 1.10M | 1.40M | 543.54K | -197.03K | -183.09K | -93.94K | -92.77K | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 3.76M | 3.73M | 7.28M | 5.33M | 5.20M | 4.29M | 1.51M | 573.72K | 292.84K | 759.85K |
Selling and marketing | -5.24B | 0 | 0 | 0 | 474.94K | 706.22K | 0 | 844.27K | 112.64K | 498.43K |
Total operating expenses | 9.01B | 9.78M | 14.33M | 9.93M | 8.86M | 10.39M | 6.68M | 3.43M | 1.83M | 3.45M |
Operating income | 0 | -8.17B | -13.69M | -9.92M | -8.74M | -10.35M | -6.77M | -3.43M | -1.83M | -3.45M |
Other income (expenses), net | 246.38M | 588.53K | -4.90M | -280.82K | 60.73K | 262.10K | 229 | -495 | -23 | -3.52K |
Income before tax | -7.66M | -7.93M | -18.60M | -10.20M | -8.68M | -10.09M | -6.70M | -3.43M | -1.83M | -3.45M |
Income tax expense | 7.1K | 13.1K | 4.80M | 360.35K | 18.61K | -262.10K | -69.54K | 495 | 47 | 3.52K |
Net income | -7.67M | -7.94M | -23.40M | -10.56M | -8.94M | -9.83M | -6.70M | -3.43M | -1.83M | -3.45M |
Earnings per share | ||||||||||
Basic EPS | -1.01 | -3.25 | -41.74 | -39.3 | -42.57 | -47.49 | -38.85 | -31.73 | -32.58 | -61.89 |
Diluted EPS | -1.01 | -3.25 | -41.74 | -39.3 | -42.57 | -47.49 | -38.85 | -31.73 | -32.58 | -61.89 |
| Data source | Data source | Data source | Data source |